stock upgrade Illumina, Belgium Genetic Centers Partner on WGS-Based Diagnostics; Evercore Upgrades Illumina Shares The San Diego-based sequencing technology firm is also launching noninvasive prenatal genetic testing on the VeriSeq v2 platform in Thailand. Illumina Upgraded to Buy by Canaccord Genuity Analyst Max Masucci told investors he believes the stock is worth owning now, regardless of uncertainty surrounding Illumina's plans to acquire Grail. Illumina Upgraded to Overweight by Piper Sandler In a note to investors, Piper Sandler analysts wrote that the upgrade reflects increased confidence in Grail and Illumina's core next-generation sequencing business. Pacific Biosciences Upgraded to Overweight by JP Morgan The investment bank also raised its price target for the company to $15, based on PacBio's strategic plan to commercialize its long-read Sequel II system. Hologic Upgraded to Outperform by Cowen on Expected Coronavirus Test Demand Cowen said that Hologic is on track to more than double its Panther system placements to about 500 this year, driven by SARS-CoV-2 test demand. May 11, 2020 William Blair Upgrades Meridian Bioscience to Outperform Feb 28, 2020 First Analysis Upgrades NeoGenomics to Strong Buy After Stock Dips Jan 2, 2020 Evercore ISI Upgrades PerkinElmer, Downgrades Hologic Nov 14, 2019 Qiagen Upgraded to Overweight by JP Morgan; Stock Surges on Thermo Fisher Buyout Speculation Oct 15, 2019 Pacific Biosciences Stock Upgraded by Piper Jaffray Jan 4, 2019 Cowen Upgrades Myriad Genetics Stock Mar 8, 2018 Raymond James Upgrades Quidel to Strong Buy Jan 2, 2018 Wells Fargo Upgrades Illumina to Outperform Dec 11, 2017 Cowen Upgrades Hologic to Outperform Sep 19, 2017 Quidel Upgraded to Overweight by Piper Jaffray on Strength of Revised Alere Asset Acquisition Jul 18, 2017 Investment Banks Upgrade Quidel Shares on Acquisition of Alere Assets Apr 21, 2017 Raymond James Upgrades Quest to Outperform Mar 7, 2017 Janney Upgrades Foundation Medicine to Neutral Feb 27, 2017 Evercore ISI Upgrades Illumina Shares to Buy Jan 4, 2017 Barclays Upgrades Agilent, Downgrades Bruker Nov 29, 2016 Janney Upgrades Veracyte to Buy Oct 3, 2016 Cepheid Leads GenomeWeb Index in September on News of Impending Acquisition by Danaher Sep 19, 2016 Cowen Upgrades GenMark Diagnostics to Outperform Jun 13, 2016 Raymond James Upgrades Quidel to Outperform Jan 6, 2016 Canaccord Genuity Upgrades Genomic Health to Buy Load More Breaking News Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.